- Division Chief, Maternal Fetal Medicine, UH Cleveland Medical Center
- Associate Professor, CWRU School of Medicine
- Intrauterine Bleeding Complicating Pregnancy
- Maternal Fetal Medicine
- Preterm Birth
- Preterm Labor
- Vaginal Bleeding Complicating Pregnancy
- Maternal and Fetal Medicine - American Board of Obstetrics and Gynecology
- Obstetrics and Gynecology - American Board of Obstetrics and Gynecology
Fellowship | Maternal and Fetal Medicine
Maternal and Fetal Medicine - Magee Women's Hospital Of Upmc (2005 - 2008)
Residency | Obstetrics and Gynecology
Obstetrics and Gynecology - Ohio State University Hospital (2000 - 2004)
University Of Pittsburgh (2008)
University Of Pittsburgh School Of Medicine (2000)
Carnegie Mellon University (1996)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, David Hackney did not disclose any Outside Relationships with Industry.